ImmusanT Expands Senior Management Team with Appointment of Thomas A. Shea as Chief Financial Officer

World News: . []

CAMBRIDGE Mass Jan 03 2019 GLOBE NEWSWIRE -- a clinical-stage LINK  leveraging its Epitope-Specific Immuno-Therapy ESIT platform to deliver first-in-class peptide-based immunomodulatory LINK  therapies to patients with LINK  une dis...

More news and information about ImmusanT, Inc.

Published By:

Globe Newswire: 14:47 GMT Thursday 3rd January 2019

Published: .

Search for other references to "immusant" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us